8-K: Cycurion Regains Nasdaq Compliance, Reports $69M Backlog

Cycurion, Inc. announced it has regained compliance with Nasdaq listing rules and reported a robust $69 million contracted backlog, underpinning a positive 2026 outlook.

Summary

• Regained compliance with Nasdaq Listing Rule 5450(b)(1)(A) (Equity Rule), demonstrating stockholders' equity of $10,448,853 as of June 30, 2025.
• Regained compliance with Nasdaq Listing Rule 5450(b)(1)(C) (MVPHS Rule), having maintained a market value of publicly held shares of $5,000,000 or greater for 10 consecutive business days from August 5, 2025, to August 18, 2025.
• Nasdaq closed the matter regarding the previous deficiency related to the minimum market value of listed securities (MVLS Rule) of $50,000,000.
• Secured $69 million in new multi-year contracts with a weighted average life of 1-5 years, which is incremental to current existing revenue-generating business.
• Recognized only a small amount of revenue from these new awards due to a typical lag between signing and work initiation, and customer deferrals.
• Maintains an active sales pipeline in the hundreds of millions.
• Current annualized run-rate revenue is $16 million, with a clear line-of-sight to returning to revenue growth and positive adjusted EBITDA in the coming quarters.
• Highlighted notable partnerships with iQSTEL, LSV Tech, and NAACHO, which provides access to approximately 3,500 state and local healthcare associations.

Sentiment

Score: 7

Explanation: The company successfully addressed critical Nasdaq compliance issues and secured a substantial backlog, providing a strong foundation for future growth. Management projects a return to revenue growth and positive adjusted EBITDA. However, current revenue is low, and customer deferrals on new contracts indicate challenges in immediate revenue conversion. Management also believes the stock is severely mispriced, suggesting a disconnect between internal outlook and market valuation.

Positives

• Successfully regained compliance with all Nasdaq listing requirements (Equity Rule and MVPHS Rule), removing the risk of delisting.
• Secured a significant $69 million in new multi-year contracts, providing a strong contracted backlog and future revenue visibility.
• An active sales pipeline in the hundreds of millions indicates substantial potential for further business expansion.
• Management expresses a bullish outlook for 2026 and beyond, supported by the backlog and pipeline.
• The company has a clear line-of-sight to returning to a revenue growth profile and achieving positive adjusted EBITDA in upcoming quarters.
• Strategic partnerships with iQSTEL, LSV Tech, and NAACHO offer inherent blue-sky opportunities and access to new markets, particularly in state and local healthcare associations.

Negatives

• Customer deferrals on commencing work for new contracts have led to a lag in revenue recognition from the $69 million backlog.
• The current annualized run-rate revenue is relatively low at $16 million, indicating a smaller operational scale.
• Management noted that 'DOGE roots' have had a negative impact on Cycurion in 2025, as well as on many public and private peers in public sector IT services.
• Management believes the stock is severely mispriced due to a 'vacuum of institutional support,' suggesting current market undervaluation.

Risks

• Customer deferrals could continue to delay the conversion of the $69 million backlog into recognized revenue, impacting financial performance.
• Forward-looking statements regarding revenue growth and positive adjusted EBITDA are subject to various factors, including economic conditions, regulatory changes, and the company's ability to address liquidity concerns.
• The unspecified 'DOGE roots' issue, which has negatively impacted the company and its peers, could persist and affect future business.
• Failure to effectively convert the active sales pipeline into signed contracts could limit future growth.
• Inability to achieve projected revenue growth and positive adjusted EBITDA could disappoint investor expectations.

Future Outlook

Management expresses a bullish stance for 2026 and beyond, underpinned by the $69 million contracted backlog and an active sales pipeline in the hundreds of millions. The company has a clear line-of-sight to returning to a revenue growth profile along with positive adjusted EBITDA in the coming quarters.

Management Comments

• "We strongly believe the combination of our positive, high confidence 2026 outlook underpinned by our contracted backlog added to what we believe is a vacuum of institutional support has resulted, in what we believe, is a severe mispricing of the stock."
• "No doubt, DOGE has had a negative impact on Cycurion in 2025 as it has on many public and private peers focused on public sector IT services."
• "We are at a fundamental trough, currently running at a $16 million annualized run-rate revenue. However, we have a clear line-of-sight of returning to a revenue growth profile along with positive adjusted EBITDA in the coming quarters."
• "We believe at our current share price investors have a limited opportunity to enter into a highly positive asymmetric risk/reward investment proposition."
• "We are determined to deliver improved results for shareholders as we move into 2026 and beyond. We will continue to announce meaningful new awards and provide updates to our signed contracted backlog position."

Industry Context

Cycurion operates in the dynamic cybersecurity and IT solutions sector, serving government, healthcare, and corporate clients. The company's focus on AI-enhanced platforms and strategic partnerships aligns with broader industry trends towards digital transformation and advanced security solutions. The mention of 'DOGE roots' impacting public sector IT services suggests a specific, albeit unexplained, external market or regulatory challenge that has affected companies in this segment in 2025.

Comparison to Industry Standards

• Cycurion's current annualized run-rate revenue of $16 million is relatively small compared to established industry leaders in government IT services and cybersecurity, such as Leidos or Booz Allen Hamilton, which report revenues in the billions.
• The $69 million contracted backlog, while a positive indicator for Cycurion's scale, is modest when compared to the multi-billion dollar backlogs typically held by major defense and government IT contractors.
• Regaining Nasdaq compliance is a fundamental requirement for publicly traded companies; the previous deficiencies (e.g., MVLS Rule requiring $50M market value) indicate past underperformance relative to market expectations for listed entities.
• The impact of 'DOGE roots' on public sector IT services, as mentioned by management, suggests a shared challenge within a specific segment of the industry, indicating that Cycurion is not alone in facing this particular headwind.

Stakeholder Impact

• Shareholders: Benefit from the removal of delisting risk due to regained Nasdaq compliance. Potential for future value creation from the significant backlog and growth projections, though management believes the stock is currently mispriced.
• Customers: Experience deferrals in project commencement for new contracts, which may impact their operational timelines and service delivery expectations.
• Employees: Continued operations and growth prospects, supported by the backlog and strategic partnerships, may provide job security and opportunities for professional development.

Next Steps

• Convert the $69 million contracted backlog into recognized revenue by initiating and delivering services for deferred contracts.
• Continue to announce meaningful new awards to further expand the backlog and sales pipeline.
• Provide regular updates to shareholders regarding the signed contracted backlog position and its conversion to revenue.
• Execute on the plan to achieve revenue growth and positive adjusted EBITDA in the coming quarters.
• Leverage strategic partnerships with iQSTEL, LSV Tech, and NAACHO to drive new business opportunities and market penetration.

Key Dates

Recommendation

While Cycurion has successfully addressed Nasdaq compliance issues and secured a substantial backlog, the current low annualized run-rate revenue and customer deferrals on new contracts suggest that significant financial improvements are not immediate. The 'DOGE roots' issue also indicates ongoing challenges. The long-term outlook is positive with projected growth and EBITDA, but investors should hold to see tangible execution on backlog conversion and financial performance before considering further investment. The stock is believed to be mispriced by management, but this needs to be validated by performance.

Keywords

cybersecurity, IT solutions, Nasdaq compliance, backlog, government contracts, AI, program management, business continuity, Cycurion